APA (7th ed.) Citation

S, L., Y, G., H, L., S, L., Y, Y., Y, Y., . . . D, P. (2026). CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer. Oncogene, 45(21), 1970. https://doi.org/10.1038/s41388-026-03786-w

Chicago Style (17th ed.) Citation

S, Li, et al. "CSF1R Inhibitors Mitigate CDK4/6 Inhibitor-induced Immunosuppression to Increase Antitumor Immunity in HR+/HER2- Breast Cancer." Oncogene 45, no. 21 (2026): 1970. https://doi.org/10.1038/s41388-026-03786-w.

MLA (9th ed.) Citation

S, Li, et al. "CSF1R Inhibitors Mitigate CDK4/6 Inhibitor-induced Immunosuppression to Increase Antitumor Immunity in HR+/HER2- Breast Cancer." Oncogene, vol. 45, no. 21, 2026, p. 1970, https://doi.org/10.1038/s41388-026-03786-w.